StonvexLoading…
StonvexCore line items from XPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $8.16B | $8.07B | $7.74B | $1.98B |
Operating Income | $656.00M | $660.00M | $438.00M | $154.00M |
Net Income | $316.00M | $387.00M | $189.00M | $84.00M |
EPS (Diluted) | $2.64 | $3.23 | $1.60 | $0.71 |
Total Assets | $8.19B | $7.71B | $7.49B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $310.00M | $246.00M | $412.00M | Not available |
Free Cash Flow OCF − CapEx | $329.00M | $19.00M | $-839.00M | Not available |
Shares Outstanding | 117.00M | 117.00M | 116.00M | Not available |